Correlation Between Acrivon Therapeutics, and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Cyteir Therapeutics, you can compare the effects of market volatilities on Acrivon Therapeutics, and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Cyteir Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Cyteir Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Acrivon and Cyteir is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Cyteir Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 27.35 times less return on investment than Cyteir Therapeutics. But when comparing it to its historical volatility, Acrivon Therapeutics, Common is 1.18 times less risky than Cyteir Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Cyteir Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 207.00 in Cyteir Therapeutics on August 31, 2024 and sell it today you would earn a total of 69.00 from holding Cyteir Therapeutics or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.29% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Cyteir Therapeutics
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acrivon Therapeutics, and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Cyteir Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |